Adapting to Pandemic Restrictions While Launching a Phase 3 Trial
The pandemic has forced companies to reimagine how trials can be conducted, and to think differently about the future of all their clinical trials.
Featured
-
Formulation Development
Formulation of Monodisperse Controlled-Release Quetiapine Microspheres
Adare’s Optimμm® technology offers a unique and efficient method of fabricating monodisperse microparticles at reduced development time.
-
Clinical Trials
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Batavia Biosciences and KU Leuven Join Forces
Will accelerate the development of a highly promising Covid-19 vaccine candidate.Contract Pharma Staff 12.03.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Injectables | Parenterals
BD to Invest $1.2B in Pre-Fillable Syringe Manufacturing Capacity
Will roll-out over the next four years and includes a new manufacturing facility in Europe.Contract Pharma Staff 12.03.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
iBio to Provide CDMO Services for ATB Therapeutics
iBio will produce ATB’s bioengineered antibody-toxin fusion proteins.Contract Pharma Staff 12.03.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Cytovance Expands Partnership with Nature Technology Corp.
Now offers NTC’s proprietary HyperGRO manufacturing platform for plasmid DNA CGMP manufacturing.Contract Pharma Staff 12.03.20
-
Breaking News | Promotions & Moves
Frontida BioPharm Appoints Chief Financial Officer
Puneet Sapra brings 20 years of pharmaceutical and healthcare experience in executive roles at Pfizer, Johnson & Johnson, and Halma.Contract Pharma Staff 12.02.20
-
Breaking News | Drug Development
ViGeneron and WuXi Advanced Therapies Enter Partnership
Will accelerate production for the clinical development of VG901, a next-generation ophthalmic gene therapy program.Contract Pharma Staff 12.02.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Sterling Makes Strategic Investment in ADC Bio
Will work together to develop an integrated service offering combining ADC Bio’s expertise with Sterling’s high potency small molecule expertise.Contract Pharma Staff 12.02.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Lonza Enters Long-term Bioconjugation Collaboration
Will construct two new customer-dedicated conjugation suites for the commercialization of antibody-drug conjugates at its Visp site.Contract Pharma Staff 12.02.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Trials & Filings
Pfizer, BioNTech Win First Authorization for COVID-19 Vax
MHRA authorizes supply of BNT162b2 vaccine for emergency supply; companies are ready to deliver the first doses to the U.K. immediately.Contract Pharma Staff 12.02.20
-
Breaking News | Drug Development | Promotions & Moves
NeuBase Therapeutics Appoints Chief Scientific Officer
Dr. Curt Bradshaw brings decades of experience in successfully delivering genetic medicines to clinics.Contract Pharma Staff 12.02.20
-
Bioanalytical Services | Breaking News | cGMP Manufacture | Industry News
KBI Biopharma Expands U.S. Ops
Invests $150 million in commercial biologics manufacturing facility in RTP, NC.Contract Pharma Staff 12.02.20
-
Bora Pharmaceuticals Acquires GSK's Ontario Facility
Broadens its range of dosage forms and enables Bora to produce 50 different products to 100 markets worldwide.Contract Pharma Staff 12.02.20
-
Analytical Services | Breaking News | Industry News | Promotions & Moves
Idifarma Strengthens Spray Drying Capabilities
Partners with industry expert Stefano Console, who will serve as scientific advisor.Contract Pharma Staff 12.01.20
- Batavia Biosciences and KU Leuven Join Forces
- Pfizer, BioNTech Win First Authorization for COVID-19 Vax
- Recipharm Inks Covid-19 Vax Pact with Moderna
- SGS Initiates U.S. COVID-19 Clinical Trials
- CureVac and Wacker Sign Contract for Manufacturing of Covid-19 Vaccine Candidate
- Merck Acquires OncoImmune for $425M
- ARCA Biopharma’s AB201 for COVID-19 Gets Fast Track
- Pfizer and BioNTech to Submit EUA for COVID-19 Vaccine
- Samsung Biologics Partners with Eli Lilly
- Delpharm to Manufacture Pfizer/BioNTech mRNA Vax in France
- Batavia Biosciences and KU Leuven Join Forces
- BD to Invest $1.2B in Pre-Fillable Syringe Manufacturing Capacity
- iBio to Provide CDMO Services for ATB Therapeutics
- Cytovance Expands Partnership with Nature Technology Corp.
- Frontida BioPharm Appoints Chief Financial Officer
- ViGeneron and WuXi Advanced Therapies Enter Partnership
- Reflect Scientific’s Cryometrix Suitable for COVID-19 Vax Air Transport
- Sterling Makes Strategic Investment in ADC Bio
- Lonza Enters Long-term Bioconjugation Collaboration
- Pfizer, BioNTech Win First Authorization for COVID-19 Vax
November/December 2020
- Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
- Ensuring Quality During the Transfer and Scale Up of Rx Drugs
- Inspecting the Unexpected
- Cold Chain Trends
- Catering for the Complex
- Biopharma Contract Manufacturing: Robust Growth Ahead
- DCAT President Talks COVID-19, Drug Manufacturing and Innovation
- The Single-Use Mixing Landscape: Evaluating Your Options
- Self-Medication: Flexibility for Patients and Drug Manufacturers
- Decentralized Trials Fuel AI Revolution in Clinical Research
Contract Service Directory
Search the Directories for A Company:
